medigraphic.com
ISSN 1561-2988 (Print)

2020, Number 1

<< Back Next >>

Rev Cubana Farm 2020; 53 (1)

Dermatophytes develop resistance to the monoterpenes geraniol and citronellol

Nunes CG, Souza SKV, de Oliveira LMI, Mendes AJM, de Oliveira PF

Language: English
References: 24
Page: 1-12
PDF size: 326.24 Kb.


ABSTRACT

Introduction: Dermatophytoses are fungal infections whose treatment has been the subject of much concern throughout the world. The emergence of antifungal resistance (azoles) in clinical therapeutics is well known. However, few studies demonstrate the capacity of dermatophytes to develop resistance against natural products such as terpenes. The monoterpenes geraniol and citronellol have recognized antifungal potential and are found in various essential oils.
Objectives: To investigate the capacity of Trichophyton rubrum, Microsporum canis, and Microsporum gypseum to acquire resistance against citronellol and geraniol.
Methods: The minimum inhibitory concentration of the tested drugs was determined by microdilution. The fungal strains were subjected to eight successive subcultures in Sabouraud dextrose agar containing the monoterpenes in sub-inhibitory concentrations. After this period of adaptation, the susceptibility profile to drugs was assessed by microdilution. Finally, after eight passages in culture medium without the drugs, resistance stability was again evaluated by microdilution test.
Results: From the initial citronellol and geraniol minimum inhibitory concentration values we observed an increase. In addition, a cross over effect was observed against the azole compounds. Finally, the fungi reversed their profiles of resistance against the natural drugs and showed no reversal in resistance to azoles. Although in dermatophytes the development of resistance to monoterpenes was observed, the phenomenon was not stable, as was observed against the azole drugs.
Conclusions: Citronellol and geraniol were active against resistant isolates even after dishabituation. Thus these monoterpenes present themselves as potential therapeutic alternatives with fewer complications in the emergence of resistance.


REFERENCES

  1. Peres NTA, Maranhão FCA, Rossi A, Martinez-Rossi NM. Dermatophytes: host-pathogen interaction and antifungal resistance. Rev Bras Dermatol. 2010;85(5):657-67.

  2. Bhagra S, Ganju AS, Kanga A, Sharma NL, Guleria RC. Mycological pattern of dermatophytosis in and around ShimLa hills. Indian J Dermatol. 2014;59(3):268-70.

  3. Faure-Cognet O, Fricker-Hidalgo H, Pelloux H, Leccia MT. Superficial fungal infections in a French teaching hospital in Grenoble area: retrospective study on 5470 samples from 2001 to 2011. Mycopathologia. 2016;181(1-2):59-66. DOI: 10.1007/s11046-015-9953-7

  4. Van Minnbruggen G, François IEJA, Cammue BPA, Thevissen K, Vroome V, Borgers M. et al. General overview on past, present and future antimycotics. The Open Mycol J. 2010;4(8):22-32.

  5. Fernández-Torres B, Inza I, Guarro J. In vitro activities of the new antifungal drug erbeconazole and three other topical agents against 200 strains of dermatophytes. J Clin Microbiol. 2003;41:5209-11.

  6. Mikhailov SN, Scotti L, Singla RK, Scotti T. Perspectives in medicinal chemistry. Curr Top Med Chem. 2016;16:2725-26.

  7. Do TKT, Hadji-Minaglou F, Antoniotti S, Fernandez X. Authenticity of essential oils. Trends Analyt Chem. 2015;66:146-57.

  8. Oliveira WA, Pereira FO, Luna CGDG, Lima IO, Wanderley PA, de Lima RB. et al. Antifungal activity of Cymbopogon winterianus Jowitt ex Bor against Candida albicans. Braz J Microbiol. 2011;42(2):433-41.

  9. Freire MM, Jham GN, Dhingra OD, Jardim CM, Barcelos, RC, Valente VMM. Composition, antifungal activity and main fungitoxic components of the essential oil of Mentha piperita L. J Food Saf. 2012;32(1):29-36.

  10. Kim E, Park IK. Fumigant antifungal activity ofMyrtaceae essential oils and constituents from Leptospermum petersonii against three Aspergillus species. Molecules. 2012;17(9):10459-69.

  11. Semmler M, Abdel-Ghaffar F, Schmidt J, Mehlhorn H. Evaluation of biological and chemical insect repellents and their potential adverse effects. Parasitol Res. 2014;113(1):185-88.

  12. Pereira FO, Mendes JM, Lima IO, Mota KS, OliveiraWA, Lima EO. Antifungal activity of geraniol and citronellol, two monoterpenes alcohols, against Trichophyton rubrum involves inhibition of ergosterol biosynthesis. Pharm Biol. 2014;53(2):228-34. DOI: 10.3109/13880209.2014.913299

  13. CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. Pennsylvania: Clinical and Laboratory Standards Institute; 2008.

  14. Santos DA, Hamdan JS. Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum. J Clin Microbiol. 2005;43(4):1917-20.

  15. Hryncewicz- Gwozdza, Kalinowska K, Plomer-Niezgoda E, Bielecki JE, Jagielski T. Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure. Mycopathologia. 2013;176(1- 2):49-55.

  16. Ghannoum M, Isham N, Verma A, Plaum S, Fleischer AJR, Hardas B. In vitro antifungal activity of naftifine hydrochloride against dermatophytes. Antimicrob Agents Chemother. 2013;57(9):4369-72. DOI: 10.1128/AAC.01084-13

  17. Ghelardi E, Celandroni AF, Gueye SA, Salvetti S, Senesi S, Bulgheroni A. et al. Potential of ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum. Antimicrob Agents Chemother. 2014;58(5):2825-29. DOI: 10.1128/AAC.02382- 13

  18. Osborne CS, Hofbauer B, Favre B, Ryder NS. In vitro analysis of the ability of Trichophyton rubrum to become resistant to terbinafine. Antimicrob Agents Chemother. 2003;47(11):3634-36.

  19. Martins MP, Franceschini ACC, Jacob TR, Rossi A, Martinez-Rossi NM. Compensatory expression of multidrug-resistance genes encoding ABC transporters in dermatophytes. J Med Microbiol. 2016;65(7):605-10. DOI: 10.1099/jmm.0.000268

  20. Santos AD, Araújo RAC, Santos AD, Kohler LM. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment. Int J Antimicrob. Agents. 2007;29(5):563-69.

  21. Borst A, Raimer MT, Warnock DW, Morrison CJ, Arthington-Skaggs BA. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob Agents Chemother. 2005;49(2):783-87.

  22. Pippi B, Lana AJ, Moraes RC, Güez CM, Machado M, de Oliveira LF. et al. In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp. J App Microbiol. 2015;118(4):839-50. DOI: 10.1111/jam.12746

  23. Ram Y, Hadany L. Stress-induced mutagenesis and complex adaptation. Proc Biol Sci 2014;281(1792): 20141025. DOI:10.1098/rspb.2014.1025

  24. Shor E, Perlin DS. Coping with stress and the emergence of multidrug resistance in fungi. PLoS Pathog. 2015;11(3):e1004668. DOI: 10.1371/journal.ppat.1004668




2020     |     www.medigraphic.com